FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Medical Devices

Hyperfine AI Swoop MR Software Cleared

FDA clears a Hyperfine 510(k) for the ninth generation of artificial intelligence-powered Swoop magnetic resonance software.

latest-news-card-1
Human Drugs

Bayer Looking to Expand Nubeqa Indication

Bayer says it will present positive results from a Phase 3 Nubeqa prostate cancer trial to FDA to consider a potential indication expansion for the dr...

latest-news-card-1
Biologics

Priority Review for Atara Gene Therapy

FDA accepts for priority review an Atara Biotherapeutics BLA for gene therapy tabelecleucel, indicated as monotherapy for treating Epstein-Barr virus-...

latest-news-card-1
FDA General

Almost 3,000 Establishment Inspections in FY 2023

The FDA FY 2023 drug and medical device establishment inspection report lists registered establishments and inspections by type and world region.

Medical Devices

Philips Updates Ventilator Instructions

FDA says a 4/1 Philips Respironics recall revising the use instructions for its OmniLab Advanced+ ventilator is Class 1.

latest-news-card-1
Medical Devices

Subtle Medical Imaging Software Cleared

FDA clears a Subtle Medical 510(k) for its SubtleSYNTH, which uses deep learning to generate synthetic Short Tau Inversion Recovery images from alread...

latest-news-card-1
Human Drugs

GMP Violations in YangZhou Records Review

FDA warns Chinas YangZhou SuXiang Medical Instrument Co. about CGMP violations in its manufacturing of finished drugs.

latest-news-card-1
Human Drugs

CGMP Violations at Jiangsu Hengrui

FDA warns Chinas Jiangsu Hengrui Pharmaceuticals about CGMP violations in its manufacturing of finished drugs

latest-news-card-1

Combination Product Application User Fees

FDA publishes a guidance on how it calculates combination product application user fees.

latest-news-card-1
Human Drugs

FDA Accepts Lexicon NDA for Resubmitted Diabetes Drug

FDA accepts for review a resubmitted Lexicon Pharmaceuticals NDA for Zynquista (sotagliflozin) as an adjunct to insulin therapy for glycemic control i...